Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 286

Showing 1-25 of 286 citing articles:

Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
Nature reviews. Neuroscience (2008) Vol. 9, Iss. 9, pp. 665-677
Closed Access | Times Cited: 500
The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease
Mona Thiruchelvam, Eric K. Richfield, Raymond B. Baggs, et al.
Journal of Neuroscience (2000) Vol. 20, Iss. 24, pp. 9207-9214
Open Access | Times Cited: 463
Falls in frequent neurological diseases
Henning Stolze, Stephan Klebe, Christiane Zechlin, et al.
Journal of Neurology (2004) Vol. 251, Iss. 1, pp. 79-84
Closed Access | Times Cited: 366
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
Anette Schrag, Jonathan M. Schott
The Lancet Neurology (2006) Vol. 5, Iss. 4, pp. 355-363
Closed Access | Times Cited: 360
Paraquat exposure as an etiological factor of Parkinson's disease
Ricardo Jorge Dinis‐Oliveira, Fernando Remião, Helena Carmo, et al.
NeuroToxicology (2006) Vol. 27, Iss. 6, pp. 1110-1122
Closed Access | Times Cited: 317
The pathogenesis of Parkinson's disease
Huw R. Morris, Maria Grazia Spillantini, Carolyn M. Sue, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 293-304
Open Access | Times Cited: 267
Exercise as medicine in Parkinson’s disease
Martin Langeskov‐Christensen, Erika Franzén, Lars G. Hvid, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 11, pp. 1077-1088
Closed Access | Times Cited: 19
Global, regional, national epidemiology and trends of Parkinson’s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021
Yuanrong Luo, Lichun Qiao, Miaoqian Li, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access | Times Cited: 2
Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake
Harvey Checkoway, Karen M. Powers, Terri Smith‐Weller, et al.
American Journal of Epidemiology (2002) Vol. 155, Iss. 8, pp. 732-738
Open Access | Times Cited: 372
A systematic review of depression and mental illness preceding Parkinson's disease
Lianna Ishihara, Carol Brayne
Acta Neurologica Scandinavica (2006) Vol. 113, Iss. 4, pp. 211-220
Closed Access | Times Cited: 299
Use of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Khaled Radad, Gabriele Gille, Linlin Liu, et al.
Journal of Pharmacological Sciences (2006) Vol. 100, Iss. 3, pp. 175-186
Open Access | Times Cited: 263
Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Lee Jia, Yuqing Zhao, Xing‐Jie Liang
Current Medicinal Chemistry (2009) Vol. 16, Iss. 22, pp. 2924-2942
Open Access | Times Cited: 257
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Rebecca Banerjee, Anatoly A. Starkov, M. Flint Beal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2008) Vol. 1792, Iss. 7, pp. 651-663
Open Access | Times Cited: 252
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Keiko Shimizu, K. Ohtaki, Keiko Matsubara, et al.
Brain Research (2001) Vol. 906, Iss. 1-2, pp. 135-142
Open Access | Times Cited: 249
The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Lea T. Grinberg, Udo Rüb, Renata Eloah de Lucena Ferretti‐Rebustini, et al.
Neuropathology and Applied Neurobiology (2009) Vol. 35, Iss. 4, pp. 406-416
Closed Access | Times Cited: 229
The Parkinson’s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activity
Luxuan Guo, Payal N. Gandhi, Wen Wang, et al.
Experimental Cell Research (2007) Vol. 313, Iss. 16, pp. 3658-3670
Open Access | Times Cited: 208
Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese
Eng‐King Tan, Celia Ia Choo Tan, Stephanie Fook‐Chong, et al.
Journal of the Neurological Sciences (2003) Vol. 216, Iss. 1, pp. 163-167
Closed Access | Times Cited: 187
The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubules
Payal N. Gandhi, Xinglong Wang, Xiongwei Zhu, et al.
Journal of Neuroscience Research (2008) Vol. 86, Iss. 8, pp. 1711-1720
Open Access | Times Cited: 169
Young-onset Parkinson's disease: Its unique features and their impact on quality of life
Raja Mehanna, Joseph Jankovic
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 39-48
Closed Access | Times Cited: 101
Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress
Siying Li, Zaoyi Wang, Gang Liu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
Integrating network pharmacology with molecular docking and dynamics to uncover therapeutic targets and signaling mechanisms of vitamin D3 in Parkinson’s disease
Cheng Wang, Yiling Wang, Qiu-Han Xu
Molecular Diversity (2025)
Closed Access | Times Cited: 1
Joint effect of modifiable risk factors on Parkinson’s disease: a large-scale longitudinal study
Panlong Li, Xirui Zhu, Min Liu, et al.
Frontiers in Human Neuroscience (2025) Vol. 19
Open Access | Times Cited: 1
Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease
Jackalina Van Kampen, H.A. Robertson, Theo Hagg, et al.
Experimental Neurology (2003) Vol. 184, Iss. 1, pp. 521-529
Closed Access | Times Cited: 160
The Coordination of Breathing and Swallowing in Parkinson’s Disease
Roxann Diez Gross, Charles W. Atwood, Sheryl B Ross, et al.
Dysphagia (2007) Vol. 23, Iss. 2, pp. 136-145
Closed Access | Times Cited: 134
Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats
Keiko Shimizu, Keiko Matsubara, K. Ohtaki, et al.
Brain Research (2003) Vol. 976, Iss. 2, pp. 243-252
Open Access | Times Cited: 134
Page 1 - Next Page

Scroll to top